Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03217838 |
| Title | Safety, Tolerability, and Efficacy of AZD2811 Nanoparticles in Patients With Relapsed AML/High-Risk Myelodysplastic Syndrome or Treatment-Naïve Patients. |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | AstraZeneca |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Denver | Colorado | 80218 | United States | Details | |
| Research Site | Sarasota | Florida | 34232 | United States | Details | |
| Research Site | Detroit | Michigan | 48201 | United States | Details | |
| Research Site | Charlotte | North Carolina | 28204 | United States | Details | |
| Research Site | Canton | Ohio | 44718 | United States | Details | |
| Research Site | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| Research Site | Nashville | Tennessee | 37203 | United States | Details | |
| Research Site | Dallas | Texas | 75246 | United States | Details | |
| Research Site | Houston | Texas | 77030 | United States | Details | |
| Research Site | Milwaukee | Wisconsin | 53226 | United States | Details | |
| Research Site | Melbourne | 3004 | Australia | Details |